Arcos Dorados to Participate in Upcoming Investor Event
Get Alerts ARCO Hot Sheet
Join SI Premium – FREE
MONTEVIDEO, Uruguay--(BUSINESS WIRE)-- Arcos Dorados Holdings Inc. (NYSE: ARCO) (“Arcos Dorados” or the “Company”), Latin America’s largest restaurant chain and the world’s largest independent McDonald’s franchisee, today announced its participation in the following investor event:
- 19th Santander LatAm Conference. This in-person event will be held in London, from Tuesday, May 23 to Wednesday, May 24, 2023, and the Company will participate on both days.
This information is also available in the Events section of the Company’s IR website: www.arcosdorados.com/ir.
Follow us on:
LinkedIn
Twitter
About Arcos Dorados
Arcos Dorados is the world’s largest independent McDonald’s franchisee, operating the largest quick service restaurant chain in Latin America and the Caribbean. It has the exclusive right to own, operate and grant franchises of McDonald’s restaurants in 20 Latin American and Caribbean countries and territories with more than 2,300 restaurants, operated by the Company or by its sub-franchisees, that together employ over 95 thousand people (as of 03/31/2023). The Company is also committed to the development of the communities in which it operates, to providing young people their first formal job opportunities and to utilize its Recipe for the Future to achieve a positive environmental impact. Arcos Dorados is listed for trading on the New York Stock Exchange (NYSE: ARCO). To learn more about the Company, please visit the Investors section of our website: www.arcosdorados.com/ir.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230502006217/en/
Investor Relations Contact
Dan Schleiniger
VP of Investor Relations Arcos Dorados
[email protected]
Media Contact
David Grinberg
VP of Corporate Communications Arcos Dorados
[email protected]
Source: Arcos Dorados Holdings Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
- Goldcana Announces Closing of Non-Brokered Private Placement Financing for $2 Million
- Best Wholesale Christmas Light Suppliers for Installers | 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share